期刊文献+

人神经生长因子对糖尿病多发性神经病大鼠坐骨神经calpainⅡ的作用 被引量:2

Effect of Human Nerve Growth Factor on CalpainⅡin Sciatic Nerves of Experimental Diabetic Polyneuropathy Rats
原文传递
导出
摘要 目的:观察人神经生长因子(hNGF)对早期糖尿病多发性神经病(DPN)大鼠坐骨神经中calpainⅡ表达的影响。方法:用链佐星(STZ)一次性腹腔注射诱导糖尿病大鼠模型,在DPN4周(造模后4周)腹腔注射hNGF90U/(kg·d),共4周。用原位杂交和免疫组化方法观察坐骨神经calpainⅡmRNA和蛋白表达。结果:DPN8周大鼠坐骨神经calpainⅡmRNA和蛋白表达明显减少。用hNGF治疗的DPN大鼠calpainⅡmRNA和蛋白表达增加。结论:hNGF治疗能纠正早期DPN大鼠坐骨神经calpainⅡmRNA和蛋白表达异常。 Aim:To observe the effect of human nerve gyowth factor(hNGF) on Calpain Ⅱ expression in sciatic nerves of experimental diabetic polyneuropathy rats. Methods: Diabetic rat was induced by a single intraperitoneally injection of streptozocin. After 4 weeks of diabetes, hNGF 90 U/( kg·d ) was injected intraperitoneally for 4 weeks. The level of calpain Ⅱ mRNA and protein expressions in sciatic nerves were measured by in situ hybridization and immunohistochemistry techniques. Results:After 8 weeks of diabetes, both calpain Ⅱ mRNA and calpain Ⅱ protein expressions were decreased significantly. Treatment with hNGF for 4 weeks, calpain Ⅱ mRNA and protein expressions were increased. Conclusion: Administration of hNGF can partly reverse abnormal expression of calpain Ⅱ in sciatic nerves of experimental diabotic polyneuropathy rats.
出处 《中国临床神经科学》 2006年第1期20-24,共5页 Chinese Journal of Clinical Neurosciences
关键词 糖尿病多发性神经病 caloainⅡ 人神经生长因子 diabetic polyneuropathy caipain Ⅱ human nerve growth factor
  • 相关文献

参考文献3

二级参考文献33

  • 1Bosio A, Binczek E, Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci USA, 1996,12,93(23): 13280
  • 2Bosio A, Bussow H, Adam J. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res, 1998,292:199
  • 3Dupree JL, Coetzee T, Suzuki K, et al. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol,1998,27(9) :649
  • 4Kalichman MW, Dines KC, Bobik M, et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin. Brain Res, 1998,810:130
  • 5Calcutt NA, Dines KC, Cessena RM. Effects of the peptide HP228on nerve disorders in diabetic rats. Metabolism, 1998,147: 650
  • 6Alichman MW, Powell HC, Mizisin AP. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol ( Berl ), 1998,95(1):47
  • 7Jurevics H, Hostettler J, Muse ED, et al. Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain. J Neurochem, 2001,77 (4):1067
  • 8Toews AD, Roe EB, Goodrum JF, et al. Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression.Brain Res Mol Brain Res, 1997,3,49 ( 1 - 2):113
  • 9Conti AM, Scarpini E, Malosio ML, et al. In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy. Neurosci Lett, 1996,207 (1): 65
  • 10Stahl N,Jurevics H, Morell P, et al. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase. J Neurosci Res, 1994,38 (2):234

共引文献21

同被引文献59

引证文献2

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部